Tumor-infiltrating γδ T cells as targets of immune checkpoint blockade in melanoma.
Marta Di SimoneAnna Maria CorsaleFrancesca ToiaMojtaba Shekarkar AzgomiAnna Barbara Di StefanoElena Lo PrestiAdriana CordovaLuigi MontesanoFrancesco DieliSerena MeravigliaPublished in: Journal of leukocyte biology (2024)
Melanoma is one of the most sensitive tumors to immune modulation, and the major challenge for melanoma patients' survival is immune checkpoint inhibitor (ICI) therapy. γδ T lymphocytes play an antitumoral role in a broad variety of tumors including melanoma and they are optimal candidates for cellular immunotherapy. Thus, a comprehensive analysis of the correlation between γδ T cells and immune checkpoint receptors in the context of melanoma was conducted, with the aim of devising an innovative combined immunotherapeutic strategy. In this study, using the GEPIA2.0 database, a significant positive correlation was observed between the expression of γδ T cell-related genes (TRGC1, TRGC2, TCRD) and immune checkpoint genes (PDCD1, HAVCR2, LAG3), highlighting the potential role of γδ T cells in the immune response within melanoma. Moreover, flow cytometry analysis unveiled a significant augmentation in the population of γδ T cells within melanoma lesions, which exhibited the expression of immune checkpoint receptors including LAG3, TIM3, and PD1. Analysis of single-cell RNA sequencing data revealed a significant enrichment and functional reprogramming of γδ T cell clusters in response to ICIs. Interestingly, the effects of ICI therapy varied between Vδ1 and Vδ2 γδ T cell subsets, with distinct changes in gene expression patterns. Last, a correlation analysis between γδ T cell abundance, immune checkpoint gene expression, and clinical outcomes in melanoma patients showed that low expression of immune checkpoint genes, including LAG3, HAVCR2, and PDCD1, was associated with improved 1-year overall survival, emphasizing the significance of these genes in predicting patient outcomes, potentially outweighing the impact of γδ T cell abundance. This study offers critical insights into the dynamic interaction between γδ T cells, immune checkpoint receptors, and melanoma, providing valuable perspectives for potential therapeutic avenues and predictive markers in this intricate interplay.
Keyphrases
- gene expression
- skin cancer
- single cell
- end stage renal disease
- poor prognosis
- immune response
- chronic kidney disease
- ejection fraction
- flow cytometry
- newly diagnosed
- basal cell carcinoma
- dna methylation
- prognostic factors
- genome wide
- emergency department
- risk assessment
- transcription factor
- deep learning
- electronic health record
- bone marrow
- patient reported outcomes
- microbial community
- long non coding rna
- wastewater treatment
- peripheral blood